GEN Exclusives

More »

GEN News Highlights

Back to Item »

Takeda’s Type 2 Diabetes Therapies Set Back Again by FDA

Postmarketing and clinical trial data on alogliptin and combination alogliptin/pioglitazone will be submitted.

Forward this item to a colleague:


(Separate multiple addresses by commas)


(Separate multiple addresses by commas)


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Uproar over Fetal Tissue Donations

Does your academic or industry lab use fetal tissue in its research?

More »